Beth Israel Deaconess Medical Center and the Dana-Farber Cancer Center wasted no time with their new partnership, yesterday telling the BPDA they will soon file detailed plans for razing the current Joslin Diabetes Center off Brookline Avenue to make way for a new, 14-story cancer hospital.
In their "letter of intent," the two Longwood Medical Area institutions say the new hospital will include 300 beds for Dana-Farber patients, 20 beds for cancer patients under short-term observation and room for new Beth Israel clinical services. The hospital basement will house both an "inpatient imaging department" and a 250-space garage.
The two say that Joslin will be moved to another building in Beth Israel's East campus, on Brookline Avenue, across Longwood Avenue from its current location.
Along with plans for the specific building, the two will also file an "institutional master plan" outlining possible development in and near the site over a ten-year period.
Dana-Farber currently has a small number of dedicated in-patient beds at Brigham and Women's Hospital. It recently announced it would drop its long-time affiliation with that hospital in favor of Beth Israel.
New Cancer Hospital filings.